Treatment of bioprosthetic tissues to mitigate post implantation calcification

• US 8,632,608 B2
• Filed: 01/17/2012
• Issued: 01/21/2014
• Est. Priority Date: 01/03/2002
• Status: Expired due to Term

• Current Assignee: Edwards Lifesciences Corporation
• Original Assignee: Edwards Lifesciences Corporation
• Inventors: Carpentier, Sophie M., Carpentier, Alain F.
• Primary Examiner(s): Douyon, Lorna M
• Assistant Examiner(s): KHAN, AMINA S
• Application Number:
  US13/352,027
• Publication Number:
  US 20120117734A1
• Time in Patent Office: 735 Days
• Field of Search: 623/11.11, 8 9/411, 422/336, 422/36
• US Class Current: 8/94.11
• CPC Class Codes: A61L 2400/02 Treatment of implants to prevent calcification or mineralisation in vivo
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3687 characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
• CPC Class Codes: B65B 63/08 for heating or cooling articles or materials to facilitate packaging

Abstract

Bioprosthetic tissues are treated by immersing or otherwise contacting fixed, unfixed or partially fixed tissue with a glutaraldehyde solution that has previously been heat-treated or pH adjusted prior to its contact with the tissue. The prior heat treating or pH adjustment of the glutaraldehyde solution causes its free aldehyde concentration to decrease by about 25% or more, preferably by as much as 50%, and allows a “stabilized” glutaraldehyde solution to be obtained at the desired concentration and pH for an optimal fixation of the tissue at high or low temperature. This treatment results in a decrease in the tissue'"'"'s propensity to calcify after being implanted within the body of a human or animal patient.

Claims

1. A method for mitigating post-implantation calcification of a bioprosthetic implant tissue, said method comprising the steps of:

obtaining biological tissue;

exposing the tissue to a fixation process to form cross-linkages in the tissue to obtain a fixed tissue;

providing a starting solution selected from the group consisting of a glutaraldehyde solution and a physiologic solution;

adjusting the pH of the starting solution to a pH of 6.0 without heating the starting solution;

immersing a quantity of the fixed tissue in the pH-adjusted solution; and

heating the pH-adjusted solution and the fixed tissue to a heat treating temperature in the range of about 30°

C. to 70°

C. for a period of time.

2. The method of claim 1, wherein the heat treating temperature is in the range of about 40°

C. to 60°

C.

3. The method of claim 1, wherein the heat treating temperature is about 50°

C.±

5°

C.

4. The method of claim 1, wherein the period of time is between about one hour and six months.

5. The method of claim 1, wherein the period of time is between about one day and two months.

6. The method of claim 1, wherein the period of time is between about 5 days to 10 days.

7. The method of claim 1, wherein the period of time is about 7 days.

8. The method of claim 1, wherein the starting solution is aqueous glutaraldehyde buffered to a starting pH, wherein the step of adjusting comprises lowering the pH.

9. The method of claim 8, wherein the starting pH is between about 7.2 to 7.8.

10. The method of claim 1, wherein the bioprosthetic implant material is a bioprosthetic heart valve, and the method further comprises the steps of:

harvesting the biological tissue from a human cadaver or animal donor;

preparing the tissue by trimming to size and washing with a suitable washing solution; and

assembling the heat treated and fixed tissue with non-biological components to form a bioprosthetic heart valve.

11. The method of claim 10, wherein the heat treating temperature is in the range of about 40°

C. to 60°

C.

12. The method of claim 10, wherein the heat treating temperature is about 50°

C.±

5°

C.

13. The method of claim 10, wherein the period of time is between about one day and two months.

14. The method of claim 10, wherein the period of time is between about 5 days to 10 days.

15. The method of claim 10, wherein the period of time is about 7 days.

16. The method of claim 10, further including, after the tissue has been fixed and heat treated, and prior to assembly into a heart valve, subjecting the fixed tissue to a first bioburden reduction process including:

contacting the fixed tissue with a mixture containing;

i) a crosslinking agent,

ii) a denaturing agent and

iii) a surfactant.

17. The method of claim 16, further including, after assembling the heart valve, subjecting the fixed tissue to a second bioburden reduction process including:

contacting the fixed tissue with a mixture containing;

i) a crosslinking agent,

ii) a denaturing agent and

iii) a surfactant.

18. The method of claim 17, wherein the second bioburden reduction process is done at a temperature of about 37°

C. for a period of time longer than the first bioburden reduction process.

19. The method of claim 18, further including storing the heart valve in a solution of glutaraldehyde.

20. The method of claim 10, wherein the starting solution is aqueous glutaraldehyde buffered to a starting pH, wherein the step of adjusting comprises lowering the pH.

21. The method of claim 20, wherein the starting pH is between about 7.2 to 7.8.